D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Visa
V
|
$319M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$288M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
$226M |
| 4 |
American Express
AXP
|
$206M |
| 5 |
Salesforce
CRM
|
$204M |
Top Sells
| 1 |
PayPal
PYPL
|
$504M |
| 2 |
Exxon Mobil
XOM
|
$356M |
| 3 |
Bank of America
BAC
|
$244M |
| 4 |
Netflix
NFLX
|
$182M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$171M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.76% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Celanese
CE
$4.89B
| $31.9M | 0.04% |
353,063
+117,493
| +50% | +$10.6M |
|
327
Roper Technologies
ROP
$56.4B
| $31.9M | 0.04% |
88,599
+27,918
| +46% | +$10M |
|
328
Teva Pharmaceuticals
TEVA
$21.5B
| $31.8M | 0.04% |
3,944,335
+2,631,829
| +201% | +$21.2M |
|
329
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.86B
| $31.8M | 0.04% |
255,200
+136,300
| +115% | +$17M |
|
330
Consolidated Edison
ED
$35.3B
| $31.8M | 0.04% |
370,918
+6,962
| +2% | +$597K |
|
331
Academy Sports + Outdoors
ASO
$3.31B
| $31.5M | 0.04% |
747,132
+173,333
| +30% | +$7.31M |
|
332
Bristol-Myers Squibb
BMY
$96.7B
| $31.4M | 0.04% |
441,853
-295,626
| -40% | -$21M |
|
|
ZEN
333
DELISTED
ZENDESK INC
ZEN
| $31.4M | 0.04% |
412,364
+354,868
| +617% | +$27M |
|
334
ChargePoint
CHPT
$252M
| $31.1M | 0.04% |
2,109,497
+1,961,462
| +1,325% | +$29M |
|
335
Humana
HUM
$37.5B
| $31M | 0.04% |
63,845
+54,499
| +583% | +$26.4M |
|
336
Workiva
WK
$4.36B
| $30.8M | 0.04% |
395,427
-71,793
| -15% | -$5.59M |
|
337
DaVita
DVA
$9.72B
| $30.5M | 0.04% |
369,073
+14,174
| +4% | +$1.17M |
|
338
Amicus Therapeutics
FOLD
$2.42B
| $30.3M | 0.04% |
2,903,496
-65,240
| -2% | -$681K |
|
339
Alnylam Pharmaceuticals
ALNY
$58.6B
| $30.3M | 0.04% |
151,144
+15,221
| +11% | +$3.05M |
|
340
Canadian Imperial Bank of Commerce
CM
$72.9B
| $30.1M | 0.04% |
687,986
-75,502
| -10% | -$3.3M |
|
341
TFI International
TFII
$7.92B
| $30M | 0.04% |
331,684
-98,600
| -23% | -$8.91M |
|
342
Kroger
KR
$45.1B
| $29.9M | 0.04% |
683,981
+519,231
| +315% | +$22.7M |
|
343
FuelCell Energy
FCEL
$91.6M
| $29.9M | 0.04% |
8,773,733
+459,123
| +6% | +$1.57M |
|
344
Invesco
IVZ
$9.68B
| $29.6M | 0.04% |
2,163,362
+1,217,808
| +129% | +$16.7M |
|
345
Tyson Foods
TSN
$20B
| $29.6M | 0.04% |
448,879
-34,114
| -7% | -$2.25M |
|
346
General Dynamics
GD
$86.8B
| $29.5M | 0.04% |
139,268
-342,630
| -71% | -$72.7M |
|
347
Host Hotels & Resorts
HST
$11.8B
| $29.4M | 0.04% |
1,849,998
+230,868
| +14% | +$3.67M |
|
348
Telus
TU
$25.1B
| $29.2M | 0.03% |
1,473,478
+67,194
| +5% | +$1.33M |
|
|
TRTL
349
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $29.2M | 0.03% |
2,970,000
| – | – |
|
350
Garmin
GRMN
$45.6B
| $29.2M | 0.03% |
363,010
+68,835
| +23% | +$5.53M |
|